Ars Pharmaceuticals Stock Analysis

ARS Stock Analysis Notes

About 17.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.84. ARS Pharmaceuticals had not issued any dividends in recent years. To find out more about ARS Pharmaceuticals contact the company at 858 771 9307 or learn more at https://ars-pharma.com.

ARS Pharmaceuticals Investment Alerts

ARS Largest EPS Surprises

View All Earnings Estimates

ARS Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

ARS Stock Institutional Investors

Note, although ARS Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ARS Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 991.45 M.

ARS Profitablity

The company has Profit Margin (PM) of (0.56) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.64) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.64.

Management Efficiency

ARS Pharmaceuticals has return on total asset (ROA) of (0.1922) % which means that it has lost $0.1922 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4592) %, meaning that it created substantial loss on money invested by shareholders. ARS Pharmaceuticals' management efficiency ratios could be used to measure how well ARS Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, ARS Pharmaceuticals' Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.02 in 2026, despite the fact that Return On Capital Employed is likely to grow to (0.01). At this time, ARS Pharmaceuticals' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 20.4 M in 2026, whereas Intangible Assets are likely to drop slightly above 4.6 M in 2026.

Technical Drivers

As of the 7th of February, ARS Pharmaceuticals shows the mean deviation of 3.92, and Risk Adjusted Performance of 0.0635. Relative to fundamental indicators, the technical analysis model gives you tools to check practical technical drivers of ARS Pharmaceuticals, as well as the relationship between them.

ARS Pharmaceuticals Price Movement Analysis

ARS Pharmaceuticals Insider Trading Activities

ARS Pharmaceuticals Outstanding Bonds

ARS Pharmaceuticals Predictive Daily Indicators

ARS Pharmaceuticals Corporate Filings

ARS Pharmaceuticals Forecast Models

ARS Pharmaceuticals' time-series forecasting models are one of many ARS Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ARS Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

ARS Pharmaceuticals Total Assets Over Time

ARS Pharmaceuticals Assets Financed by Debt

The debt-to-assets ratio shows the degree to which ARS Pharmaceuticals uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

ARS Pharmaceuticals Debt Ratio

0.0131

It appears most of the ARS Pharmaceuticals' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the ARS Pharmaceuticals' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of ARS Pharmaceuticals, which in turn will lower the firm's financial flexibility.

ARS Pharmaceuticals Corporate Bonds Issued

ARS Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how ARS Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ARS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ARS Pharmaceuticals. By using and applying ARS Stock analysis, traders can create a robust methodology for identifying ARS entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ARS analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ARS analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

ARS Pharmaceuticals stock analysis indicators help investors evaluate how ARS Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ARS Pharmaceuticals shares will generate the highest return on investment. By understating and applying ARS Pharmaceuticals stock analysis, traders can identify ARS Pharmaceuticals position entry and exit signals to maximize returns.

When running ARS Pharmaceuticals' price analysis, check to measure ARS Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARS Pharmaceuticals is operating at the current time. Most of ARS Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ARS Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ARS Pharmaceuticals' price. Additionally, you may evaluate how the addition of ARS Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.